USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; text-indent: 35.4pt; line-height: 200%; text-align: justify; mso-pagination: none; mso-layout-grid-align: none;"><span style="mso-ansi-language: EN-GB;" lang="EN-GB"><span styl...
Main Authors: | Claudio Ucciferri, Katia Falasca, Paola Mancino, Eligio Pizzigallo, Jacopo Vecchiet |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2010-02-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Subjects: | |
Online Access: | http://www.mjhid.org/article/view/5582 |
Similar Items
-
USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS
by: Paola Mancino, et al.
Published: (2010-03-01) -
Cardiac toxicity associated with HCV direct antiviral agents
by: Claudio Ucciferri, et al.
Published: (2018-10-01) -
Induction with ribavirin in a relapsing patient with chronic HCV hepatitis
by: Claudio Ucciferri, et al.
Published: (2012-05-01) -
Treatment Related Hematologic Changes in a Population of Iranian Patients with Chronic Hepatitis C Infection from 2009 to 2014
by: Zahra AHMADINEJAD, et al.
Published: (2017-10-01) -
Hematological Side Effects During Combination Therapy With Interferon and Ribavirin In Chronic Hepatitis C
by: Komal Owais
Published: (2015-06-01)